Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
Identifieur interne : 000D54 ( PubMed/Checkpoint ); précédent : 000D53; suivant : 000D55Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
Auteurs : Danielle Needle [États-Unis] ; George T. Lountos [États-Unis] ; David S. Waugh [États-Unis]Source :
- Acta crystallographica. Section D, Biological crystallography [ 1399-0047 ] ; 2015.
Descripteurs français
- KwdFr :
- Antienzymes (pharmacologie), Antiviraux (pharmacologie), Conformation des protéines, Coronavirus du syndrome respiratoire du Moyen-Orient (enzymologie), Cristallographie aux rayons X, Cysteine endopeptidases (), Cysteine endopeptidases (métabolisme), Domaine catalytique, Données de séquences moléculaires, Humains, Modèles moléculaires, Similitude de séquences d'acides aminés, Spécificité du substrat, Séquence d'acides aminés.
- MESH :
- enzymologie : Coronavirus du syndrome respiratoire du Moyen-Orient.
- métabolisme : Cysteine endopeptidases.
- pharmacologie : Antienzymes, Antiviraux.
- Conformation des protéines, Cristallographie aux rayons X, Cysteine endopeptidases, Domaine catalytique, Données de séquences moléculaires, Humains, Modèles moléculaires, Similitude de séquences d'acides aminés, Spécificité du substrat, Séquence d'acides aminés.
English descriptors
- KwdEn :
- Amino Acid Sequence, Antiviral Agents (pharmacology), Catalytic Domain, Crystallography, X-Ray, Cysteine Endopeptidases (chemistry), Cysteine Endopeptidases (metabolism), Enzyme Inhibitors (pharmacology), Humans, Middle East Respiratory Syndrome Coronavirus (enzymology), Models, Molecular, Molecular Sequence Data, Protein Conformation, Sequence Homology, Amino Acid, Substrate Specificity.
- MESH :
- chemical , chemistry : Cysteine Endopeptidases.
- chemical , metabolism : Cysteine Endopeptidases.
- chemical , pharmacology : Antiviral Agents, Enzyme Inhibitors.
- enzymology : Middle East Respiratory Syndrome Coronavirus.
- Amino Acid Sequence, Catalytic Domain, Crystallography, X-Ray, Humans, Models, Molecular, Molecular Sequence Data, Protein Conformation, Sequence Homology, Amino Acid, Substrate Specificity.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic virus that causes severe respiratory illness accompanied by multi-organ dysfunction, resulting in a case fatality rate of approximately 40%. As found in other coronaviruses, the majority of the positive-stranded RNA MERS-CoV genome is translated into two polyproteins, one created by a ribosomal frameshift, that are cleaved at three sites by a papain-like protease and at 11 sites by a 3C-like protease (3 CL(pro)). Since 3 CL(pro) is essential for viral replication, it is a leading candidate for therapeutic intervention. To accelerate the development of 3 CL(pro) inhibitors, three crystal structures of a catalytically inactive variant (C148A) of the MERS-CoV 3 CL(pro) enzyme were determined. The aim was to co-crystallize the inactive enzyme with a peptide substrate. Fortuitously, however, in two of the structures the C-terminus of one protomer is bound in the active site of a neighboring molecule, providing a snapshot of an enzyme-product complex. In the third structure, two of the three protomers in the asymmetric unit form a homodimer similar to that of SARS-CoV 3 CL(pro); however, the third protomer adopts a radically different conformation that is likely to correspond to a crystallographic monomer, indicative of substantial structural plasticity in the enzyme. The results presented here provide a foundation for the structure-based design of small-molecule inhibitors of the MERS-CoV 3 CL(pro) enzyme.
DOI: 10.1107/S1399004715003521
PubMed: 25945576
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25945576Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.</title>
<author><name sortKey="Needle, Danielle" sort="Needle, Danielle" uniqKey="Needle D" first="Danielle" last="Needle">Danielle Needle</name>
<affiliation wicri:level="2"><nlm:affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lountos, George T" sort="Lountos, George T" uniqKey="Lountos G" first="George T" last="Lountos">George T. Lountos</name>
<affiliation wicri:level="2"><nlm:affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Waugh, David S" sort="Waugh, David S" uniqKey="Waugh D" first="David S" last="Waugh">David S. Waugh</name>
<affiliation wicri:level="2"><nlm:affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25945576</idno>
<idno type="pmid">25945576</idno>
<idno type="doi">10.1107/S1399004715003521</idno>
<idno type="wicri:Area/PubMed/Corpus">000E23</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E23</idno>
<idno type="wicri:Area/PubMed/Curation">000E23</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E23</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000D54</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D54</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.</title>
<author><name sortKey="Needle, Danielle" sort="Needle, Danielle" uniqKey="Needle D" first="Danielle" last="Needle">Danielle Needle</name>
<affiliation wicri:level="2"><nlm:affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lountos, George T" sort="Lountos, George T" uniqKey="Lountos G" first="George T" last="Lountos">George T. Lountos</name>
<affiliation wicri:level="2"><nlm:affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Waugh, David S" sort="Waugh, David S" uniqKey="Waugh D" first="David S" last="Waugh">David S. Waugh</name>
<affiliation wicri:level="2"><nlm:affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Acta crystallographica. Section D, Biological crystallography</title>
<idno type="eISSN">1399-0047</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Catalytic Domain</term>
<term>Crystallography, X-Ray</term>
<term>Cysteine Endopeptidases (chemistry)</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus (enzymology)</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Protein Conformation</term>
<term>Sequence Homology, Amino Acid</term>
<term>Substrate Specificity</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antienzymes (pharmacologie)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Conformation des protéines</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (enzymologie)</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases ()</term>
<term>Cysteine endopeptidases (métabolisme)</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Modèles moléculaires</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Spécificité du substrat</term>
<term>Séquence d'acides aminés</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Cysteine Endopeptidases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cysteine Endopeptidases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cysteine endopeptidases</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antienzymes</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Catalytic Domain</term>
<term>Crystallography, X-Ray</term>
<term>Humans</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Protein Conformation</term>
<term>Sequence Homology, Amino Acid</term>
<term>Substrate Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conformation des protéines</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Modèles moléculaires</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Spécificité du substrat</term>
<term>Séquence d'acides aminés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic virus that causes severe respiratory illness accompanied by multi-organ dysfunction, resulting in a case fatality rate of approximately 40%. As found in other coronaviruses, the majority of the positive-stranded RNA MERS-CoV genome is translated into two polyproteins, one created by a ribosomal frameshift, that are cleaved at three sites by a papain-like protease and at 11 sites by a 3C-like protease (3 CL(pro)). Since 3 CL(pro) is essential for viral replication, it is a leading candidate for therapeutic intervention. To accelerate the development of 3 CL(pro) inhibitors, three crystal structures of a catalytically inactive variant (C148A) of the MERS-CoV 3 CL(pro) enzyme were determined. The aim was to co-crystallize the inactive enzyme with a peptide substrate. Fortuitously, however, in two of the structures the C-terminus of one protomer is bound in the active site of a neighboring molecule, providing a snapshot of an enzyme-product complex. In the third structure, two of the three protomers in the asymmetric unit form a homodimer similar to that of SARS-CoV 3 CL(pro); however, the third protomer adopts a radically different conformation that is likely to correspond to a crystallographic monomer, indicative of substantial structural plasticity in the enzyme. The results presented here provide a foundation for the structure-based design of small-molecule inhibitors of the MERS-CoV 3 CL(pro) enzyme.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25945576</PMID>
<DateCompleted><Year>2016</Year>
<Month>02</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-0047</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>71</Volume>
<Issue>Pt 5</Issue>
<PubDate><Year>2015</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Acta crystallographica. Section D, Biological crystallography</Title>
<ISOAbbreviation>Acta Crystallogr. D Biol. Crystallogr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.</ArticleTitle>
<Pagination><MedlinePgn>1102-11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1107/S1399004715003521</ELocationID>
<Abstract><AbstractText>Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic virus that causes severe respiratory illness accompanied by multi-organ dysfunction, resulting in a case fatality rate of approximately 40%. As found in other coronaviruses, the majority of the positive-stranded RNA MERS-CoV genome is translated into two polyproteins, one created by a ribosomal frameshift, that are cleaved at three sites by a papain-like protease and at 11 sites by a 3C-like protease (3 CL(pro)). Since 3 CL(pro) is essential for viral replication, it is a leading candidate for therapeutic intervention. To accelerate the development of 3 CL(pro) inhibitors, three crystal structures of a catalytically inactive variant (C148A) of the MERS-CoV 3 CL(pro) enzyme were determined. The aim was to co-crystallize the inactive enzyme with a peptide substrate. Fortuitously, however, in two of the structures the C-terminus of one protomer is bound in the active site of a neighboring molecule, providing a snapshot of an enzyme-product complex. In the third structure, two of the three protomers in the asymmetric unit form a homodimer similar to that of SARS-CoV 3 CL(pro); however, the third protomer adopts a radically different conformation that is likely to correspond to a crystallographic monomer, indicative of substantial structural plasticity in the enzyme. The results presented here provide a foundation for the structure-based design of small-molecule inhibitors of the MERS-CoV 3 CL(pro) enzyme.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Needle</LastName>
<ForeName>Danielle</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lountos</LastName>
<ForeName>George T</ForeName>
<Initials>GT</Initials>
<AffiliationInfo><Affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Waugh</LastName>
<ForeName>David S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo><Affiliation>Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName>
<AccessionNumberList><AccessionNumber>4WMD</AccessionNumber>
<AccessionNumber>4WME</AccessionNumber>
<AccessionNumber>4WMF</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y"><Grant><GrantID>HHSN261200800001E</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><Acronym>ImNIH</Acronym>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>04</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Acta Crystallogr D Biol Crystallogr</MedlineTA>
<NlmUniqueID>9305878</NlmUniqueID>
<ISSNLinking>0907-4449</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="C099456">3C-like proteinase, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3CLpro</Keyword>
<Keyword MajorTopicYN="N">MERS-CoV</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">main protease</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>02</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25945576</ArticleId>
<ArticleId IdType="pii">S1399004715003521</ArticleId>
<ArticleId IdType="doi">10.1107/S1399004715003521</ArticleId>
<ArticleId IdType="pmc">PMC4427198</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Biochem. 2010 Sep;148(3):349-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20587646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2006 May 19;281(20):13894-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16565086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2014 May 24;383(9931):1793</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24868566</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20383002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2000 Sep 8;302(1):205-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10964570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2010;5(10):e13197</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20949131</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20057044</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Eng. 2001 Dec;14(12):993-1000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11809930</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2006 Dec 12;45(49):14632-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17144656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2009;498:297-307</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18988033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS J. 2006 Mar;273(5):1035-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16478476</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS J. 2014 Sep;281(18):4085-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25039866</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virulence. 2014 Aug 15;5(6):650-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25089913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2012;3(6). pii: e00473-12. doi: 10.1128/mBio.00473-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS J. 2013 May;280(9):2002-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23452147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biopolymers. 1983 Dec;22(12):2577-637</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6667333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2005 Sep 2;280(35):31257-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15788388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2009 Jun 5;388(2):324-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19409595</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21460441</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15572779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2010 Sep 3;285(36):28134-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20489209</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Appl Crystallogr. 2009 Dec 1;42(Pt 6):1035-1042</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22477774</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(11):e27228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22073294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2014 Aug;10(8):e1004250</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25144235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24753421</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2000 Apr;81(Pt 4):853-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10725411</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2013 Nov 28;503(7477):535-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24172901</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods. 2011 Sep;55(1):94-106</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21821126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2010 May 25;49(20):4308-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20420403</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16855301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 May;82(9):4620-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18305031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2007 Feb 23;366(3):916-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17196984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Oct;88(19):11297-303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25031349</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2005 Nov 11;353(5):1137-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16219322</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biophys J. 2010 Apr 7;98(7):1327-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20371333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2002 Mar;83(Pt 3):595-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11842254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21460454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Pharm Des. 2006;12(35):4573-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17168763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Sep;82(17):8647-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18562531</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2007 Feb 23;366(3):965-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17189639</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Comput Biol. 2011 Feb;7(2):e1001084</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21390281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Mar;82(5):2515-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18094151</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Recent Pat Antiinfect Drug Discov. 2013 Aug;8(2):150-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23879823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Dec;87(23):12611-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24027335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 2002 Jul 1;21(13):3213-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12093723</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W597-603</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22661580</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20057045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2008 Jan 4;283(1):554-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17977841</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jun 4;279(23):24765-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15037623</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Needle, Danielle" sort="Needle, Danielle" uniqKey="Needle D" first="Danielle" last="Needle">Danielle Needle</name>
</region>
<name sortKey="Lountos, George T" sort="Lountos, George T" uniqKey="Lountos G" first="George T" last="Lountos">George T. Lountos</name>
<name sortKey="Waugh, David S" sort="Waugh, David S" uniqKey="Waugh D" first="David S" last="Waugh">David S. Waugh</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000D54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:25945576 |texte= Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25945576" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |